New breast cancer drug added to PBS
Australians living with advanced breast cancer now have access to life-saving medicine thanks to the Morrison Government’s listing of Verzenio® (abemaciclib) to the Pharmaceutical Benefits Scheme (PBS).
Federal Member for Bonner Ross Vasta MP said the new drug would treat non-premenopausal patients with advanced hormone receptor positive human epidermal growth factor receptor 2 negative breast cancer.
“Before being listed on the PBS, this drug would cost patients up to $55,000 per year,” Mr Vasta said.
“Now for the more than 3000 patients with this type of breast cancer, the drug will only cost $41 per script and only $6.60 for concessional patients.
“The Morrison Government is committed to supporting all breast cancer patients, with the hope they may overcome this horrible disease and continue leading a full and healthy life.”
Minister for Health Greg Hunt said this was just another way the Morrison Government was saving lives and protecting lives.
“It is estimated around 19,000 women and 160 men will be diagnosed with breast cancer in Australia in 2020,” Minister Hunt said.
“Australia has one of the highest survival rates or breast cancer in the world, with the five year survival rate at almost 91 per cent.
“The Morrison Government is committed to ensuring all Australians have access to affordable medicines when they need them.”